Drug industry writers propose code of ethical conduct

BMJ 2002; 324 doi: http://dx.doi.org/10.1136/bmj.324.7341.808/e (Published 6 April 2002)
Cite this as: BMJ 2002;324:808.6

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Gavin Yamey
  1. Oakland

    A group of pharmaceutical industry writers is urging all drug companies to adopt a new code of conduct that gives guidance on ethical publication practice.

    The code, called Good Publication Practice for Pharmaceutical Companies, includes a commitment to register and publish all trials and to avoid redundant or duplicate publication.

    The code was discussed at last week's …

    Get access to this article and all of bmj.com for the next 14 days

    Sign up for a 14 day free trial today

    Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL